scorecardresearchGranules India Share Price Live NSE, BSE, Today - Granules India Stock
Mintgenie
Asian Paints2,844.60-16.95 (-0.59%)
Axis Bank1,130.052.70 (0.24%)
Bajaj Finance6,729.85-564.05 (-7.73%)
Bajaj Finserv1,597.10-58.70 (-3.55%)
Bharti Airtel1,325.50-10.45 (-0.78%)
HCL Technologies1,476.80-26.85 (-1.79%)
HDFC Bank1,509.75-0.90 (-0.06%)
Hindustan Unilever2,221.50-9.50 (-0.43%)
ICICI Bank1,107.15-5.90 (-0.53%)
ITC439.952.45 (0.56%)
Indusind Bank1,445.85-50.30 (-3.36%)
Infosys1,430.15-8.25 (-0.57%)
Kotak Mahindra Bank1,608.40-34.60 (-2.11%)
Larsen & Toubro3,602.30-48.35 (-1.32%)
Mahindra & Mahindra2,055.00-40.55 (-1.94%)
Maruti Suzuki India12,687.05-219.05 (-1.70%)
NTPC355.75-2.55 (-0.71%)
Nestle India2,483.80-78.90 (-3.08%)
Power Grid Corporation Of India292.60-0.50 (-0.17%)
Reliance Industries2,903.00-15.40 (-0.53%)
State Bank Of India801.40-11.20 (-1.38%)
Sun Pharmaceutical Industries1,504.25-16.30 (-1.07%)
Tata Consultancy Services3,825.00-26.85 (-0.70%)
Tata Motors999.35-1.45 (-0.14%)
Tata Steel165.85-1.75 (-1.04%)
Tech Mahindra1,277.4587.35 (7.34%)
Titan Company3,584.4011.75 (0.33%)
Ultratech Cement9,735.3551.75 (0.53%)
Wipro464.653.65 (0.79%)

Granules India

BSE: 532482 | NSE: GRANULES | ISIN: INE101D01020 | SECTOR: Biotechnology & Drugs

₹426.45 8.85 (2.12%)

26 Apr 2024, 09:59 (IST)

  • Open

    417.55

  • High

    427.85

  • Low

    414.95

  • Prev Close

    417.60

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    103.36B

  • Volume

    24.59K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    -
View all metrics

Promoter Pledge Holding - 1.69%

Promoter NameNo of SharesPercentage
KRISHNA PRASAD CHIGURUPATI41,00,0001.69%

Company Description

  • Biotechnology & Drugs

  • BSE

    532482

  • NSE

    GRANULES

  • ISIN

    INE101D01020

Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over eight manufacturing facilities, approximately seven of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.

Company Officers

  • Krishna Chigurupati

    Executive Chairman of the Board, Managing Director

  • Kandiraju Rao

    Chief Executive Officer, Joint Managing Director, Executive Director

  • Mukesh Surana

    Chief Financial Officer

  • Anil Arora

    Corporate Executive

  • Atul Dhavle

    Chief Human Resource Officer

  • Sanjay Kumar

    Senior Vice President - Corporate Strategy & Planning

  • G. N. Prashanth

    Senior Vice President & Head Corporate Quality

  • Manikandan Ramalingam

    Senior Vice President & Head Formulation R&D

  • Sethu Sankaran

    Senior Vice President - API Manufacturing & Operations

  • Chaitanya Tummala

    Compliance Officer, Company Secretary